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Abstract
Introduction Physical activity is an important component in
promoting a healthy life style in cancer survivors. We esti-
mated the proportion of cancer survivors who are physically
active, defined as meeting public health exercise guidelines,
and changes in level of physical activity (LPA) from before
diagnosis to after treatment. We also identified medical and
demographic factors associated with LPA and its changes.
Methods A cross-sectional survey assessing LPA before
diagnosis and after treatment, together with demographic
and medical variables in 975 cancer survivors.
Results Forty-five percent of the cancer survivors were
physically active after treatment. Before diagnosis and after
treatment 33% were active, whereas 40% were inactive at
both time points. Fifteen percent were active before diagnosis
but inactive after treatment, and 12% were inactive before
diagnosis but active after treatment. Increasing age and
weight, low education, comorbidity and smoking were
associated with physical inactivity after treatment. Change in
LPA from active to inactive was associated with comorbidity,
distant disease and smoking, while a change from inactive to
active was associated with high education.
Conclusions Less than half of cancer survivors were
physically active. Almost three quarters of cancer survivors
remained stable in LPA. The remaining quarter changed
LPA, with slightly more cancer survivors becoming inactive
than active. Age, weight, education, comorbidity, disease
stage and smoking can identify survivors at risk of physical
inactivity after treatment.
Implications for cancer survivors Recognizable variables
can be used to identify physically inactive cancer survivors
after treatment and give these survivors support to start or
maintain LPA.
Keywords Exercise guidelines.Physical activity change.
Cancer survivors
Introduction
The number of cancer survivors is increasing and estimates
show that over 900,000 people in the Nordic countries are
living with ongoing cancer or a history of cancer [1].
Approximately 65% diagnosed with cancer in the Western
world today can expect to live for at least 5 years [2, 3].
Due to the malignancy itself and its treatment, many
patients experience various acute and chronic adverse
effects that affect quality of life (QoL) [4–6]. Compared
to the general population, cancer survivors also face a
higher risk of secondary cancer, osteoporosis, overweight
and cardiovascular diseases [7–10]. In general, there is
substantial documentation showing that physical activity
(PA) prevents or at least reduces some of these adverse
effects [11]. Several studies have recently shown positive
effects of PA among cancer survivors both on physical and
psychological health, and overall QoL [12–14], as well as
an association between PA and survival [15, 16].
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DOI 10.1007/s11764-010-0148-4Despite documented benefits of exercise, only 25–30%
of cancer survivors are reported to be physically active [17–
20]. Physically active individuals are in this report defined
as individuals who meet the public health exercise guide-
lines [21]. Admittedly these guidelines have changed over
time and may vary between countries [21, 22]( www.
helsedirektoratet.no). Young age, male, high education,
healthy weight and absence of comorbidity are factors
shown to be to be positively associated with PA among
cancer survivors [20, 23–27].
Studies indicate that about 30–60% of cancer survivors
who were active before diagnosis do not return to their pre-
diagnosis level of physical activity (LPA) [28, 29], but
factors associated with change in LPA have received
limited attention. However, Lynch and colleagues found
that being female, low level of education and having
received adjuvant therapy were associated with a decrease
in LPA from pre-diagnosis to post-treatment among
colorectal cancer patients [26]. In order to reduce morbidity
after cancer treatment, the goal should be to increase the
number of physically active cancer survivors. Identification
of demographic and medical factors associated with LPA
and its changes may provide important knowledge about
the risk to be a physically active or an inactive cancer
survivor. Interventions focusing on PA should primarily
focus on the latter individuals.
The primary aim ofthe present studywas 1)toestimatethe
proportion of physically active cancer survivors and to assess
the percentage of individuals who change their LPA from
before diagnosis to after treatment. The secondary aim was to
identify medical and demographic factors associated with
LPA and its changes. Based on previous research in cancer
survivors [17–20, 23–28], we hypothesized that at least one
quarter of Norwegian cancer survivors would be physically
active. Further, we hypothesized that about one third of
cancer survivors would report a lower LPA after treatment
than before diagnosis. We expected that age, weight,
education, comorbidity and smoking, treatment or extension
of the disease (stage) would be associated with LPA and its
changes from before diagnosis to after treatment.
Materials and methods
Study participants and procedure
Thiscross-sectionalstudywasconductedfromFebruary2007
to September 2007. Consecutive patients were identified from
the Norwegian Radium Hospital (NRH)’s patient registry and
were eligible for the analysis if the medical databases did not
show any disease activity at the time of the survey, with
exception of testicular cancer and malignant lymphoma, since
many of these patients are cured despite metastases at time of
diagnosis. Patients were aged between 18 and 75 when first
seen at the hospital. They had received curatively intended
treatment at the NRH between January 2002 and December
2005 for malignant lymphoma, breast, testicular, cervical,
ovarian or prostate cancer. Among all available breast cancer
patients only a random third was selected because of the large
number in this group. Due to small groups, cervical cancer
and ovarian cancer were combined as ‘gynecological cancer’
in the analyses. Treatment (except for adjuvant hormone
treatment) should have been finalized prior to the study.
Eligible participants received an information letter, a
questionnaire and a pre-paid envelope, with a follow-up
reminder letter to non-responders after four weeks. Ethical
approval was obtained from the institutional review board
and the regional ethics committee for medical research. All
participants signed an informational consent form.
Measures
Information on gender, age, diagnosis, time since diagnosis
and disease stage (localized/regional/distant) was collected
from the medical databases at the hospital. The remaining
variables were obtained by self-report and included: weight
and height, married/cohabitant, education, employment
status, comorbidity [defined as any long-lasting physical or
psychological illnesses (cancer excluded) which had led to
reduced daily life functions during the last year], treatment
[one local treatment/two local treatments/systemic treatment/
one local treatment + systemic treatment/two local treat-
ments + systemic treatment (local treatment including surgery
and/or radiotherapy and systemic treatment including chemo-
therapy and/or hormone therapy)], and daily smoking.
The patients recorded their LPA prior to diagnosis and their
post-treatment LPA (at the time of survey) by a modified
version of the Leisure Score Index from the Godin Leisure
Time Exercise Questionnaire (GLTEQ) [30]. The GLTEQ
assesses average frequency and duration of intensity: mild
(e.g. easy walking), moderate (e.g. brisk walking) and
vigorous (e.g. running) exercise in a typical week. The
GLTEQ has been found to be both valid and reliable [31].
Two independent translators following standard forward and
backward translation procedures translated the GLTEQ into
Norwegian [32]. In our study the proportion of respondents
meeting exercise guidelines (counted as ≥150 min of
moderate intensity or ≥75 min of vigorous intensity a week)
was calculated considering LPA before diagnosis and LPA
aftertreatmentseparately[21]. Patients not meeting the public
exercise guidelines were categorized as physically inactive,
irrespective of the individual level of sub-optimal activity.
Change in LPA resulted in four post-treatment categories,
taken into account whether or not respondents were meeting
exercise guidelines at the two time points: “maintainers”:
meeting exercise guidelines at both time points, “persistently
36 J Cancer Surviv (2011) 5:35–43inactives”: not meeting exercise guidelines before diagnosis
or after treatment, “adopters”: not meeting exercise guide-
lines before diagnosis but after treatment, “relapsers”:
meeting exercise guidelines before diagnosis but not after
treatment.
Statistical analyses
Except for descriptive methods, logistic regression analyses
were used to evaluate factors associated with 1: being
physically active versus being inactive after treatment, 2:
being a relapser versus being a maintainer and 3: being an
adopter versus being persistently inactive. Demographic
and medical variables statistically significant in unadjusted
analyses were included as explanatory variables in the
multiple regression analyses. The final models were
reduced to include statistically significant variables only.
Gender was not included as an explanatory variable in the
logistic regression analyses because four out of five
diagnoses were gender-specific, which made it impossible
to separate diagnosis and gender in overall analyses.
Adjusted odds ratios (aOR) are presented with 95%
confidence intervals (95% CI). All analyses were performed
with SPSS 16.0 (SPSS, Chicago, IL). A two-tailed P value
of less than 0.05 was considered statistically significant.
Results
Participant compliance
Of 2,024 patients who were invited to participate in the
survey, 43 envelopes were returned unopened (19 persons
had moved to an unknown address and 24 were recently
deceased). Of 1,981 eligible participants, 1,356 returned the
completed questionnaire package. Of these, 72 patients
were excluded because of recurrence at the time of survey
according to the medical database, resulting in 1,284
participants. Due to missing responses as to GLTEQ, we
had 975 analyzable participants and a response rate of 51%
(975 of 1,909). Fifty-six percent were female, 75% were
married/cohabitant and 42% had high education (Table 1).
The median age was 56.1 years (range 21.6–80.0) and the
median number of months since diagnosis was 41.0 (range
14.3–103.5) (data not shown).
Prevalence of cancer survivors being physically active
and changes in LPA
Based on the overall sample of 975 cancer survivors
reporting their LPA both pre-diagnosis and post-treatment,
48% of the participants were physically active before
diagnosis and 45% were physically active after treatment
Table 1 Demographic and medical characteristics of participants
Variable Total n (%)
No. of participants 975
Demographic
Gender
Male 432 (44)
Female 543 (56)
Age (years)
Middle-aged adult 45–64 464 (48)
Young adult <45 years 265 (27)
Older adults ≥65 246 (25)
BMI (n=934)
Healthy <25 kg/m
2 445 (48)
Overweight 25–29.9 kg/m
2 350 (37)
Obese ≥30 kg/m
2 139 (15)
Married/cohabitant (n=974)
No 248 (25)
Yes 726 (75)
Education (n=972)
Primary/secondary school 157 (16)
High school 412 (42)
College/university <4 yrs 223 (23)
College/university ≥4 yrs 180 (19)
Employment status (n=974)
Fulltime/student/military service 445 (46)
Part-time/homemaker 137 (14)
Retired 217 (22)
Disability benefit/sick leave/unemployed 175 (18)
Medical
Comorbidity (n=945)
No 664 (70)
Yes 281 (30)
Time since diagnosis
<2 years 112 (11)
≥2 years 863 (89)
Diagnosis
Lymphoma 245 (25)
Testicular 139 (14)
Breast 241 (25)
Gynecological (cervix and ovarian) 204 (21)
Prostate 146 (15)
Treatment (n=970)
One local treatment 136 (14)
Two local treatments 155 (16)
Systemic treatment 109 (11)
One local treatment + systemic treatment 356 (37)
Two local treatments + systemic treatment 214 (22)
Disease stage (n=972)
Localized 482 (50)
Regional 297 (30)
Distant 193 (20)
Daily smoking (n=972)
No 812 (84)
Yes 160 (16)
Numbers may not add up to 975 because of missing data
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52% and 55%. In total, 323 (33%) maintained physically
active both before diagnosis and after treatment, 392 (40%)
were persistently inactive, 149 (15%) relapsed in LPA, while
111 (12%) adopted in LPA (Fig. 1). Of the 472 pre-diagnosis
physically active survivors, 149 (32%) were categorized as
relapsers and 323 (68%) maintained their LPA after
treatment (Table 3). Of the 503 pre-diagnosis physically
inactive survivors, 111 (22%) became adopters and 392
(78%) were persistently inactive after treatment (Table 4).
Factors associated with being physically active
after treatment
In unadjusted logistic regression analyses, being physically
active after treatment was negatively associated with age
65+ years, overweight and obesity, retirement, receiving
disability benefit/sick leave/unemployment, comorbidity,
distant disease and smoking, and was positively associated
with higher education (Table 2). Results from multiple
logistic regression analyses showed that older age remained
negatively associated with being physically active [aOR
0.62; 95% CI (0.44–0.88), p=0.008] (Table 2). Overweight
and obesity were also negatively associated with being
physically active [aOR 0.73; 95% CI (0.54–0.98), p=0.03
and aOR 0.46; 95% CI (0.3–0.71), p<0.001, respectively].
Participants with comorbidity had approximately 50%
reduced odds of being physically active compared to those
with no comorbidity [aOR 0.56; 95% CI (0.41–0.76), p<
0.001]. Compared to non-smokers, smokers were about half
as likely to be physically active [aOR 0.53; 95% CI (0.36–
0.78), p=0.001]. High education was positively associated
with being physically active [aOR 2.05; 95% CI (1.26–
3.33), p=0.004] (Table 2).
Factors associated with being a relapser and an adopter
In unadjusted analyses, being a relapser was associated with
obesity,receivingdisabilitybenefit/sickleave/unemployment,
comorbidity, distant disease and smoking (Table 3). In
multiplelogisticregressionanalyses,presenceofcomorbidity
resulted in about 2.5 higher odds of being a relapser
compared to the participants with no comorbidity [aOR
2.47; 95% CI (1.6–3.81), p<0.001] (Table 3). Cancer
survivors with distant disease were more than twice as
likely to become a relapser compared to the ones with
localized disease [aOR 2.17; 95% CI (1.28–3.66), p=0.004].
Smoking also remained associated with being a relapser
[aOR 1.79; 95% CI (1.04–3.09), p=0.04]. High education
(college/university ≥4 years) was the only factor statistically
significantly associated with being an adopter both in
unadjusted and multiple logistic regression analysis [aOR
2.29; 95% CI (1.13–4.63), p=0.02] (Table 4).
Discussion
Our study showed that almost half of all surveyed cancer
survivors were physically active after treatment. In the
overall sample, one third were maintainers, 40% were
persistently inactives and about one quarter changed their
LPA. Among those being physically active before diagnosis,
about one third relapsed in LPA. Among those who were
inactive before diagnosis, more than one fifth adopted in
LPA. Moreover, the results demonstrated that participants
who were 65+ years, those with a non-healthy weight, or low
educated, had comorbidities and smoked were less likely to
be physically active. Being a relapser was associated with
comorbidity, distant disease and smoking, and being an
adopter was associated with high education.
The large sample size made it possible to perform
subgroup analyses. Further, information on LPA both
before diagnosis and after treatment made it possible to
perform analyses on the change of LPA across the cancer
experience, even though the patients provided the relevant
information retrospectively. Validated questionnaires of
LPA were applied. Medical variables (diagnosis, time since
diagnosis and disease stage) were collected from medical
Fig. 1 Categorizing cancer sur-
vivors based on whether or not
they were meeting exercise
guidelines before diagnosis and
after treatment (n=975)
38 J Cancer Surviv (2011) 5:35–43Table 2 Prevalence of physically active cancer survivors after treatment and factors associated with being physically active (versus being
inactive) (n=975)
Physically actives% Unadjusted analyses Adjusted analyses
a
Yes No cOR 95%CI P aOR 95%CI P
All (n=975) 45 55
N 434 541
Diagnosis (n=975)
Lymphoma (reference) 42 58 1.0 0.68
Testicle 47 53 1.25 0.82–1.89 0.30
Breast 47 53 1.24 0.87–1.77 0.24
Gynecological (cervix and ovarian) 42 58 1.01 0.69–1.46 0.98
Prostate 45 55 1.11 0.73–1.67 0.63
Age (years) (n=975)
Middle-aged adult 45–64 (reference) 46 54 1.0 0.06 1.0 0.03
Young adult <45 years 48 52 1.08 0.8–1.47 0.59 0.86 0.62–1.2 0.37
Older adult ≥65 38 62 0.73 0.53–0.99 0.049 0.62 0.44–0.88 0.008
BMI (n=934)
Healthy <25 kg/m
2 (reference) 51 49 1.0 <0.001 1.0 0.001
Overweight 25-29.9 kg/m
2 43 57 0.75 0.57–0.99 0.046 0.73 0.54–0.98 0.03
Obese ≥30 kg/m
2 30 70 0.42 0.31–0.69 <0.001 0.46 0.3–0.71 <0.001
Married/cohabitant (n=974)
No (reference) 48 52 1.0
Yes 43 57 0.83 0.62–1.1 0.2
Education (n=972)
Primary/secondary school (reference) 34 66 1.0 0.001 1.0 0.04
High school 42 58 1.42 0.97–2.09 0.07 1.42 0.93–2.16 0.11
College/university <4 yrs 48 52 1.84 1.21–2.81 0.005 1.55 0.97–2.47 0.07
College/university ≥4 yrs 55 45 2.4 1.54–3.73 <0.001 2.05 1.26–3.33 0.004
Employment status (n=974)
Fulltime/student/military service (reference) 50 50 1.0 0.004
Part-time/homemaker 44 56 0.77 0.52–1.13 0.18
Retired 40 60 0.66 0.48–0.92 0.01
Disability benefit/sick leave/unemployed 35 65 0.54 0.38–0.78 0.001
Comorbidity (n=945)
No (reference) 49 51 1.0 1.0
Yes 33 67 0.53 0.39–0.7 <0.001 0.56 0.41–0.76 <0.001
Time since diagnosis (years) (n=975)
<2 years (reference) 48 52 1.0
≥2 years 44 56 0.85 0.57–1.25 0.4
Treatment (n=970)
One local treatment (reference) 39 61 1.0 0.2
Two local treatments 46 54 1.36 0.85–2.17 0.2
Systemic treatment 37 63 0.91 0.54–1.53 0.72
One local treatment + systemic treatment 47 53 1.42 0.95–2.12 0.09
Two local treatments + systemic treatment 46 54 1.32 0.86–2.05 0.21
Disease stage (n=972)
Localized (reference) 46 54 1.0 0.04
Regional 47 53 1.02 0.77–1.37 0.88
Distant 36 64 0.66 0.47–0.93 0.02
Daily smoking (n=972)
No (reference) 47 53 1.0 1.0
Yes 34 66 0.58 0.41–0.83 0.003 0.53 0.36–0.78 0.001
Numbers may not add up to 975 because of missing data
cOR crude odds ratio, aOR adjusted odds ratio. 95% CI, 95% Confidence Interval
aNumbers included in the multivariate analyses were 902
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Proportion of relapsers% Unadjusted analyses Adjusted analyses
a
Yes No cOR 95%CI P aOR 95%CI P
All physical active before diagnosis (n=472) 32 68
N 149 323
Diagnosis (n=472)
Lymphoma (reference) 37 63 1.0 0.09
Testicle 30 70 0.75 0.41–1.37 0.35
Breast 27 73 0.64 0.37–1.11 0.12
Gynecological (cervix and ovarian) 39 61 1.08 0.62–1.88 0.79
Prostate 20 80 0.43 0.21–0.89 0.02
Age (years) (n=472)
Middle-aged adult 45–64 (reference) 31 69 1.0 0.25
Young adult <45 years 36 64 1.28 0.83–1.98 0.26
Older adults ≥65 26 74 0.81 0.47–1.38 0.44
BMI (n=454)
Healthy <25 kg/m
2 (reference) 28 72 1.0 0.02
Overweight 25–29.9 kg/m
2 33 67 1.26 0.82–1.95 0.3
Obese ≥30 kg/m
2 48 52 2.42 1.3–4.5 0.005
Married/cohabitant (n=471)
No (reference) 32 68 1.0
Yes 31 69 0.97 0.63–1.49 0.89
Education (n=470)
Primary/secondary school (reference) 36 64 1.0 0.26
High school 33 67 0.87 0.47–1.6 0.65
College/university <4 yrs 33 67 0.88 0.46–1.7 0.71
College/university ≥4 yrs 23 77 0.53 0.26–1.09 0.08
Employment status (n=471)
Fulltime/student/military service (reference) 27 73 1.0 0.003
Part-time/homemaker 35 65 1.43 0.78–2.62 0.25
Retired 24 76 0.86 0.49–1.52 0.6
Disability benefit/sick leave/unemployed 47 53 2.38 1.44–3.93 0.001
Comorbidity (n=453)
No (reference) 26 74 1.0 1.0
Yes 48 52 2.7 1.77–4.15 <0.001 2.47 1.6–3.81 <0.001
Time since diagnosis (years) (n=472)
<2 years (reference) 34 66 1.0
≥2 years 31 69 0.89 0.51–1.54 0.67
Treatment (n=469)
One local treatment (reference) 32 68 1.0 0.09
Two local treatments 19 81 0.5 0.22–1.16 0.11
Systemic treatment 40 60 1.44 0.65–3.19 0.37
One local treatment + systemic treatment 34 66 1.11 0.57–2.16 0.75
Two local treatments + systemic treatment 30 70 0.9 0.43–1.89 0.78
Disease stage (n=471)
Localized (reference) 27 73 1.0 0.009 1.0 0.02
Regional 31 69 1.22 0.78–1.93 0.39 1.25 0.77–2.02 0.37
Distant 44 56 2.17 1.32–3.56 0.002 2.17 1.28–3.66 0.004
Daily smoking (n=472)
No (reference) 29 71 1.0 1.0
Yes 44 56 1.9 1.13–3.13 0.02 1.79 1.04–3.09 0.04
Numbers may not add up to 472 because of missing data
cOR crude odds ratio, aOR adjusted odds ratio. 95% CI, 95% Confidence Interval
aNumbers included in the multivariate analyses were 452
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Proportion of adopters% Unadjusted analyses Adjusted analyses
a
Yes No cOR 95%CI P aOR 95%CI P
All physically inactive at before diagnosis (n=503) 22 78
N 111 392
Diagnosis (n=503)
Lymphoma (reference) 19 81 1.0 0.53
Testicle 18 82 0.97 0.44–2.16 0.94
Breast 24 76 1.39 0.75–2.58 0.29
Gynecological (cervix and ovarian) 27 73 1.56 0.84–2.91 0.16
Prostate 20 80 1.06 0.53–2.15 0.86
Age (years) (n=503)
Middle-aged adult 45–64 (reference) 24 76 1.0 0.08
Young adult <45 years 27 73 1.15 0.69–1.93 0.58
Older adults ≥65 16 84 0.6 0.36–1.02 0.06
BMI (n=480)
Healthy <25 kg/m
2 (reference) 23 77 1.0 0.48
Overweight 25–29.9 kg/m
2 25 75 1.11 0.7–1.77 0.65
Obese ≥30 kg/m
2 18 82 0.75 0.4–1.42 0.38
Married/cohabitant (n=503)
No (reference) 25 75 1.0
Yes 21 79 0.83 0.51–1.36 0.47
Education (n=502)
Primary/secondary school (reference) 16 84 1.0 0.04 1.0 0.04
High school 19 81 1.22 0.65–2.31 0.54 1.22 0.65–2.31 0.54
College/university <4 yrs 27 73 1.94 0.97–3.86 0.06 1.94 0.97–3.86 0.06
College/university ≥4 yrs 31 69 2.29 1.13–4.63 0.02 2.29 1.13–4.63 0.02
Employment status (n=503)
Fulltime/student/military service (reference) 26 74 1.0 0.1
Part-time/homemaker 27 73 1.09 0.61–1.97 0.77
Retired 17 83 0.59 0.34–1.02 0.06
Disability benefit/sick leave/unemployed 17 83 0.58 0.3–1.12 0.10
Comorbidity (n=492)
No (reference) 24 76 1.0
Yes 17 83 0.63 0.39–1.04 0.07
Time since diagnosis (years) (n=503)
<2 years (reference) 23 77 1.0
≥2 years 22 78 1.07 0.70–1.64 0.74
Treatment (n=501)
One local treatment (reference) 22 78 1.0 0.11
Two local treatments 16 84 0.66 0.30–1.45 0.31
Systemic treatment 12 88 0.46 0.17–1.24 0.13
One local treatment + systemic treatment 26 74 1.21 0.65–2.24 0.56
Two local treatments + systemic treatment 27 73 1.28 0.67–2.46 0.45
Disease stage (n=501)
Localized (reference) 24 76 1.0 0.21
Regional 23 77 0.95 0.59–1.53 0.83
Distant 15 85 0.57 0.3–1.07 0.08
Daily smoking (n=500)
No (reference) 24 76 1.0
Yes 15 85 0.57 0.3–1.06 0.08
Numbers may not add up to 503 because of missing data
cOR crude odds ratio, aOR adjusted odds ratio. 95% CI, 95% Confidence Interval
aNumbers included in the multivariate analyses were 502
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compared to self-report.
Our study might be limited by the possibility of selection
bias given the response rate of only 51%. Unfortunately,
information about the non-responders was not available.
There is a chance that participants completing the ques-
tionnaire were those with a particular interest in PA, and
thus more physically active than the non-respondents,
leading to a relatively high prevalence of physically active
cancer survivors. Nevertheless, similar limitations would
also affect other studies regarding cancer survivors’ LPA
[17–20]. Moreover, we have to be aware of the weakness of
self-reported information and that individuals tend to
overestimate their actual LPA and intensity compared with
objective measurements [33]. A recent report from The
Norwegian Directorate of Health shows that only about half
of the self-reported physically actives were confirmed
physically active with objective measures [34]. A frequent
gap between objective and subjective reporting of LPA is
thus evident. Recall bias could also be a source of error.
Finally, the cross-sectional design does not allow causal
inference on associations between the independent varia-
bles and PA. Further, prospective studies following the
changes in LPA across the cancer experience should be
explored.
Contrary to our expectations and previous findings
[17–20], our results show a relatively high prevalence of
cancer survivors meeting exercise guidelines. Except for
the possible above mentioned selection bias or an over-
reporting of LPA, another explanation could be that
Norwegian cancer survivors are more physically active
than reported from Northern-America and Australia [17–
20]. Other Norwegian studies showed that survivors of
Hodgkins lymphoma and testicular cancer had a higher
LPA compared to the general population [35, 36].
Unexpectedly, there were only 3% more relapsers than
adopters in total. In contrast, Karvinen and colleagues [37]
found that twice as many relapsed than adopted among
bladder cancer survivors. Additionally, 68% of the partic-
ipants in the Canadian study were inactive both before
diagnosis and after treatment, which is much higher than in
the present study. This could probably be due to unavoid-
able inter-study variations (age, type of cancer, culture etc.).
Consistent with our hypothesis and previous findings,
low age, healthy weight, high education, absence of
comorbidity and a non-smoking life style were associated
with being physically active after treatment [23–27].
Contrary to our hypothesis, no association between being
physically active and treatment or disease stage was
observed in the multivariable analysis which indicates that
these medical factors were of less importance.
The present study suggests that being a relapser is
associated with comorbidity and thus that individuals with
more comorbidities may be in particular need of post-
treatment assistance with physical activity in order to regain
maximal health. This finding is in accordance with Coups
et al. who found that lung cancer survivors with more
comorbidities were more likely to become sedentary after
treatment [38]. As expected, we observed an association
between disease stage and a decrease in LPA. Somewhat
this is in line with Lynch and colleagues who reported an
association between having received adjuvant therapy
(chemotherapy and/or radiotherapy) and a decrease in
LPA [26]. It is reasonable to assume that treatment could
be linked to the extension of the disease. Not surprisingly,
our results indicate that being an adopter is associated with
higher education. Approximately half of the adopters had
higher education, whereas only one third of the persistently
inactives had higher education. People with high education
probably acknowledged post-treatment health benefits of
PA, and for some the cancer diagnosis may have positively
influenced upon a subsequent healthy behavior. In the
literature this is described as a ‘teachable moment’ that may
play an important role in guiding survivors toward a life
style that improve overall health [39].
In conclusion, the present study indicates that less than
half of the cancer survivors were physically active after
treatment. Approximately three quarters of the cancer
survivors remained stable in their LPA, whereas the
remaining quarter changed their LPA with about half of
them in a negative direction. Overall, the findings indicate a
more positive trend than expected. Demographic and
medical variables as age, weight, education, comorbidity,
disease stage and smoking can help identify cancer
survivors at risk of physical inactivity after treatment.
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